19. Kaludov N, et al. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Human
Gene Therapy. 2002;13(10):1235–43.
20. Kalbfuss B. et al. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography.
Biotechnol Bioeng. 2007;96(5):932–944.
21. Novais JL, Titchener-Hooker NJ, Hoare M. Economic comparison between conventional and disposables-based technology for
the production of biopharmaceuticals. Biotechnol and Bioengi. 2001;75(2):143–153.
22. Gen Engi news. 2004;24(8).
23. 3rd Annual Report and Survey of Biopharmaceutical Manufacturing, Capacity and Production.
24. Sinclair A, Monge M. Biomanufacturing for the 21st Century: Designing a concept facility based on single-use systems.
BioProcess Int. 2004 Oct supp:26–31.
|
